Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
Newest: New drugs of 2010
|
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
Does your pharmacy use social media (blog, Facebook, Twitter, etc.) as a marketing tool?
• Yes
• No
• We plan on using social media in 2011
|
|
|
A new website, HealthCareandYou.org, has been created to educate pharmacists, other health professionals, and patients about the Affordable Care Act. Read full article. |
 |
|
|
 |
A monthly review of the peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.
|
Benefit of compression stockings after stroke is modest
Read full article.
|
Late last week, King Pharmaceuticals, a subsidiary of Pfizer, voluntarily recalled Embeda (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a schedule II controlled substance, from all U.S. wholesalers and retailers. Read full article. |
|
Children 6 to 23 months of age who receive trivalent inactivated flu vaccine concurrently with the 13-valent pneumococcal conjugate vaccine are at increased risk of febrile seizures, according to researchers at the Centers for Disease Control and Prevention in Atlanta and Harvard Medical School in Boston. Read full article. |
|
|
The anticancer drug bevacizumab could help prevent babies with retinopathy of prematurity from becoming blind, reports a new study from the University of Texas Health Science Center at Houston Medical School.
Read full article.
|
|
The risk of certain birth defects is higher in women given opioid analgesics such as hydrocodone during pregnancy, a new study reported. Read full article.
|
|
The angiogenesis inhibitor bevacizumab, used with chemotherapy or biological therapy, carries an increased risk of treatment-related death in cancer patients compared with chemotherapy alone, a new study shows. Read full article.
|
|
FDA notified healthcare professionals of serious health risks that have been reported in premature babies receiving lopinavir/ritonavir (Kaletra, Abbott) oral solution. Read full article.
 |
Meetings and Events
March 24, 2011 Regional NACDS-DEA Meeting
10:00 a.m.-3:00 p.m.
Houston, Texas
Contact:
Magalie Normil
413 North Lee Street
Alexandria, VA
22313-1480
[email protected]
March 25-27, 2011 NCPA Diabetes Accreditation Standards-Practical Applications (DASPA)
Dallas, TX
Contact:
100 Daingerfield Road
Alexandria, VA
22314
800-544-7447
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
April 16, 2011 Diabetes, Oral Health, & Nutrition: Interrelationships, Innovations, & Interventions
San Francisco, CA
Health professionals not eligible for continuing medical education credit will receive a certificate of participation
that they may submit to their state licensing board for credit.
Contact:
Joslin Diabetes Center
One Joslin Place
Boston, MA 02215
617-732-2400
www.ProfessionalEd.joslin.org
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
 Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
